世界の肺がん治療市場：治療法別 (非侵襲および低侵襲)、治療タイプ別 (標的療法、免疫療法、化学療法、放射線療法、およびその他の治療法)、適応症別 (非小細胞肺がん(NSCLC)、小細胞肺がん(SCLC)、カルチノイド)、エンドユーザー別 (病院、腫瘍クリニック、研究センターなど)、地域規模別、動向、COVID-19の影響、2029年までの予測
世界の肺がん治療市場は、2023年に325億ドルと評価されました。市場価値は2029年までに703億9000万ドルに達すると予想されます。肺がん治療は腫瘍学の重要な分野であり、世界で最も一般的で致命的ながんの1つである肺がんの治療に焦点を当てています。従来、肺がんの治療は化学療法と放射線療法に大きく依存していました。しかし、近年、標的療法や免疫療法の開発と採用が急増しており、治療へのアプローチに革命をもたらしています。
今後、世界の肺がん治療市場はその成長軌道を継続すると予想されます。併用療法の探索を含む新しい治療法の継続的な研究開発により、副作用の少ないより効果的な治療選択肢を提供することが期待されています。プレシジョンメディシンの採用の増加と、患者の層別化を改善するためのバイオマーカーの開発によって治療成績がさらに向上します。
さらに、がん治療の改善と新薬の承認に対する政府の取り組みと財政支援が市場拡大を促進します。。より多くの患者が高度な治療法にアクセスできるようになり、肺がんの世界的な負担が増加するにつれて、肺がん治療の需要が高まる可能性があり、今後数年間は市場の成長を維持し2024年から2029年の予測期間中に約14%のCAGRで成長すると予想されます。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Lung Cancer Therapy: An Overview
2.1.1 Introduction to Lung Cancer Therapy
2.2 Lung Cancer Therapy Segmentation: An Overview
3. Global Market Analysis
3.1 Global Lung Cancer Therapy Market: An Analysis
3.1.1 Global Lung Cancer Therapy Market: An Overview
3.1.2 Global Lung Cancer Therapy Market by Value
3.1.3 Global Lung Cancer Therapy Market by Treatment Method (Non-Invasive and Minimally Invasive)
3.1.4 Global Lung Cancer Therapy Market by Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies)
3.1.5 Global Lung Cancer Therapy Market by Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Carcinoid)
3.1.6 Global Lung Cancer Therapy Market by End-User (Hospitals, Oncology Clinics, Research Centers, and Others)
3.1.7 Global Lung Cancer Therapy Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
3.2 Global Lung Cancer Therapy Market: Treatment Method Analysis
3.2.1 Global Lung Cancer Therapy Market by Treatment Method: An Overview
3.2.2 Global Non-Invasive Lung Cancer Therapy Market by Value
3.2.3 Global Minimally Invasive Lung Cancer Therapy Market by Value
3.2.4 Global Minimally Invasive Lung Cancer Therapy Market by Type (Radiofrequency Ablation, Microwave Ablation, Photodynamic Ablation, Thermal Ablation, Cryoablation, Chemical Ablation, and Others)
3.2.5 Global Minimally Invasive Lung Cancer Therapy Market Type by Value
3.3 Global Lung Cancer Therapy Market: Therapy Type Analysis
3.3.1 Global Lung Cancer Therapy Market by Therapy Type: An Overview
3.3.2 Global Lung Cancer Targeted Therapy Market by Value
3.3.3 Global Lung Cancer Immunotherapy Market by Value
3.3.4 Global Lung Cancer Chemotherapy Market by Value
3.3.5 Global Lung Cancer Radiation Therapy Market by Value
3.3.6 Global Lung Cancer Other Therapy Market by Value
3.4 Global Lung Cancer Therapy Market: Indication Analysis
3.4.1 Global Lung Cancer Therapy Market by Indication: An Overview
3.4.2 Global Non-Small Cell Lung Cancer (NSCLC) Therapy Market by Value
3.4.3 Global Small Cell Lung Cancer (SCLC) Therapy Market by Value
3.4.4 Global Carcinoid Lung Cancer Therapy Market by Value
3.5 Global Lung Cancer Therapy Market: End-User Analysis
3.5.1 Global Lung Cancer Therapy Market by End-User: An Overview
3.5.2 Global Lung Cancer Therapy Hospitals Market by Value
3.5.3 Global Lung Cancer Therapy Oncology Clinics Market by Value
3.5.4 Global Lung Cancer Therapy Research Centers Market by Value
3.5.5 Global Lung Cancer Therapy Others Market by Value
4. Regional Market Analysis
4.1 North America Lung Cancer Therapy Market: An Analysis
4.1.1 North America Lung Cancer Therapy Market: An Overview
4.1.2 North America Lung Cancer Therapy Market by Value
4.1.3 North America Lung Cancer Therapy Market by Region (The US, Canada, and Mexico)
4.1.4 The US Lung Cancer Therapy Market by Value
4.1.5 Canada Lung Cancer Therapy Market by Value
4.1.6 Mexico Lung Cancer Therapy Market by Value
4.2 Europe Lung Cancer Therapy Market: An Analysis
4.2.1 Europe Lung Cancer Therapy Market: An Overview
4.2.2 Europe Lung Cancer Therapy Market by Value
4.2.3 Europe Lung Cancer Therapy Market by Region (Germany, The UK, France, Italy, Spain, and Rest of Europe)
4.2.4 Germany Lung Cancer Therapy Market by Value
4.2.5 The UK Lung Cancer Therapy Market by Value
4.2.6 France Lung Cancer Therapy Market by Value
4.2.7 Italy Lung Cancer Therapy Market by Value
4.2.8 Spain Lung Cancer Therapy Market by Value
4.2.9 Rest of Europe Lung Cancer Therapy Market by Value
4.3 Asia Pacific Lung Cancer Therapy Market: An Analysis
4.3.1 Asia Pacific Lung Cancer Therapy Market: An Overview
4.3.2 Asia Pacific Lung Cancer Therapy Market by Value
4.3.3 Asia Pacific Lung Cancer Therapy Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific)
4.3.4 China Lung Cancer Therapy Market by Value
4.3.5 Japan Lung Cancer Therapy Market by Value
4.3.6 India Lung Cancer Therapy Market by Value
4.3.7 South Korea Lung Cancer Therapy Market by Value
4.3.8 Rest of Asia Pacific Lung Cancer Therapy Market by Value
4.4 Latin America Lung Cancer Therapy Market: An Analysis
4.4.1 Latin America Lung Cancer Therapy Market: An Overview
4.4.2 Latin America Lung Cancer Therapy Market by Value
4.5 Middle East & Africa Lung Cancer Therapy Market: An Analysis
4.5.1 Middle East & Africa Lung Cancer Therapy Market: An Overview
4.5.2 Middle East & Africa Lung Cancer Therapy Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Lung Cancer Therapy Market
5.2 Post COVID-19 Impact on Global Lung Cancer Therapy Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Incidences of Lung Cancer
6.1.2 Aging Population
6.1.3 Rising Healthcare Expenditure
6.1.4 Growing Pollution Levels
6.1.5 Increasing Prevalence of Smoking and Unhealthy Lifestyles
6.1.6 Government Initiatives for Lung Cancer Screening and Treatment
6.2 Challenges
6.2.1 High Cost of Lung Cancer Treatment
6.2.2 Adverse Effect of Lung Cancer Therapy
6.3 Market Trends
6.3.1 New Product Development and Launches
6.3.2 The Arrival of Nanomedicine
6.3.3 Growing Demand for Targeted Therapy
6.3.4 Emergence of New Medical Diagnostics Equipment and Advanced Therapies
6.3.5 Advancement in Precision Medicine
6.3.6 Growth of Combination Therapy
6.3.7 Increasing Focus on Patient-centered Care
7. Competitive Landscape
7.1 Global Lung Cancer Therapy Market: Competitive Landscape
7.2 Global Lung Cancer Therapy Market Players by Product Pipeline
8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Business Overview
8.1.2 Sales by Operating Business
8.1.3 Business Strategy
8.2 Eli Lilly and Company
8.2.1 Business Overview
8.2.2 Revenue by Product Category
8.2.3 Business Strategy
8.3 Bristol-Myers Squibb Company
8.3.1 Business Overview
8.3.2 Revenue by Region
8.3.3 Business Strategy
8.4 Merck Group
8.4.1 Business Overview
8.4.2 Net Sales by Business Sector
8.4.3 Business Strategy
8.5 Pfizer Inc.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Sanofi
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategies
8.7 Novartis AG
8.7.1 Business Overview
8.7.2 Operating Regions
8.7.2 Operating Regions
8.8 Johnson & Johnson
8.8.1 Business Overview
8.8.2 Operating Segment
8.8.3 Business Strategy
8.9 Abbvie Inc.
8.9.1 Business Overview
8.9.2 Net Revenue by Therapeutic Area
8.9.3 Business Strategy
8.10 AstraZeneca
8.10.1 Business Overview
8.10.2 Revenue by Region
8.10.3 Business Strategy
8.11 Boehringer Ingelheim Pharmaceuticals, Inc.
8.11.1 Business Overview
8.11.2 Net Sales by Business
8.11.3 Business Strategy
8.12 Amgen Inc.
8.12.1 Business Overview
8.12.2 Operating Regions
8.12.3 Business Strategy
List of Figures
Figure 1: Lung Cancer Therapy Segmentation
Figure 2: Global Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 3: Global Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 4: Global Lung Cancer Therapy Market by Treatment Method; 2023 (Percentage, %)
Figure 5: Global Lung Cancer Therapy Market by Therapy Type; 2023 (Percentage, %)
Figure 6: Global Lung Cancer Therapy Market by Indication; 2023 (Percentage, %)
Figure 7: Global Lung Cancer Therapy Market by End-User; 2023 (Percentage, %)
Figure 8: Global Lung Cancer Therapy Market by Region; 2023 (Percentage, %)
Figure 9: Global Non-Invasive Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Non-Invasive Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 11: Global Minimally Invasive Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 12: Global Minimally Invasive Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 13: Global Minimally Invasive Lung Cancer Therapy Market by Type; 2023 (Percentage, %)
Figure 14: Global Minimally Invasive Lung Cancer Therapy Market Type by Value; 2019-2023 (US$ Billion)
Figure 15: Global Minimally Invasive Lung Cancer Therapy Market Type by Value; 2024-2029 (US$ Billion)
Figure 16: Global Lung Cancer Targeted Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 17: Global Lung Cancer Targeted Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 18: Global Lung Cancer Immunotherapy Market by Value; 2019-2023 (US$ Billion)
Figure 19: Global Lung Cancer Immunotherapy Market by Value; 2024-2029 (US$ Billion)
Figure 20: Global Lung Cancer Chemotherapy Market by Value; 2019-2023 (US$ Billion)
Figure 21: Global Lung Cancer Chemotherapy Market by Value; 2024-2029 (US$ Billion)
Figure 22: Global Lung Cancer Radiation Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 23: Global Lung Cancer Radiation Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 24: Global Lung Cancer Other Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 25: Global Lung Cancer Other Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 26: Global Non-Small Cell Lung Cancer (NSCLC) Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 27: Global Non-Small Cell Lung Cancer (NSCLC) Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 28: Global Small Cell Lung Cancer (SCLC) Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 29: Global Small Cell Lung Cancer (SCLC) Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 30: Global Carcinoid Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 31: Global Carcinoid Lung Cancer Therapy Market by Value; 2024-2029 (US$ Million)
Figure 32: Global Lung Cancer Therapy Hospitals Market by Value; 2019-2023 (US$ Billion)
Figure 33: Global Lung Cancer Therapy Hospitals Market by Value; 2024-2029 (US$ Billion)
Figure 34: Global Lung Cancer Therapy Oncology Clinics Market by Value; 2019-2023 (US$ Billion)
Figure 35: Global Lung Cancer Therapy Oncology Clinics Market by Value; 2024-2029 (US$ Billion)
Figure 36: Global Lung Cancer Therapy Research Centers Market by Value; 2019-2023 (US$ Billion)
Figure 37: Global Lung Cancer Therapy Research Centers Market by Value; 2024-2029 (US$ Billion)
Figure 38: Global Lung Cancer Therapy Others Market by Value; 2019-2023 (US$ Billion)
Figure 39: Global Lung Cancer Therapy Others Market by Value; 2024-2029 (US$ Billion)
Figure 40: North America Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 41: North America Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 42: North America Lung Cancer Therapy Market by Region; 2023 (Percentage, %)
Figure 43: The US Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 44: The US Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 45: Canada Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 46: Canada Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 47: Mexico Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 48: Mexico Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 49: Europe Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 50: Europe Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 51: Europe Lung Cancer Therapy Market by Region; 2023 (Percentage, %)
Figure 52: Germany Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 53: Germany Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 54: The UK Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 55: The UK Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 56: France Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 57: France Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 58: Italy Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 59: Italy Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 60: Spain Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 61: Spain Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 62: Rest of Europe Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 63: Rest of Europe Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 64: Asia Pacific Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 65: Asia Pacific Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 66: Asia Pacific Lung Cancer Therapy Market by Region; 2023 (Percentage, %)
Figure 67: China Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 68: China Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 69: Japan Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 70: Japan Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 71: India Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 72: India Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 73: South Korea Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 74: South Korea Lung Cancer Therapy Market by Value; 2024-2029 (US$ Million)
Figure 75: Rest of Asia Pacific Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 76: Rest of Asia Pacific Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 77: Latin America Lung Cancer Therapy Market by Value; 2019-2023 (US$ Billion)
Figure 78: Latin America Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 79: Middle East & Africa Lung Cancer Therapy Market by Value; 2019-2023 (US$ Million)
Figure 80: Middle East & Africa Lung Cancer Therapy Market by Value; 2024-2029 (US$ Billion)
Figure 81: The US Estimated Number of New Lung and Bronchus Cancer Cases; 2020-2024 (Thousand)
Figure 82: Global Percentage of Population Aged 65 Years or Above; 2018-2023 (Percentage, %)
Figure 83: Global Healthcare Expenditure as a Share of GDP; 2022-2029 (Percentage, %)
Figure 84: F. Hoffmann-La Roche Ltd. Sales by Operating Business; 2023 (Percentage, %)
Figure 85: Eli Lilly and Company Revenue by Product Category; 2023 (Percentage, %)
Figure 86: Bristol-Myers Squibb Company Revenue by Region; 2023 (Percentage, %)
Figure 87: Merck Group Net Sales by Business Sector; 2023 (Percentage, %)
Figure 88: Pfizer Inc. Total Revenues by Segment; 2023 (Percentage, %)
Figure 89: Sanofi Net Sales by Segments; 2023 (Percentage, %)
Figure 90: Novartis AG Net Sales by Region; 2023 (Percentage, %)
Figure 91: Johnson & Johnson Sales by Segment; 2023 (Percentage,%)
Figure 92: Abbvie Inc. Net Revenue by Therapeutic Area; 2023 (Percentage, %)
Figure 93: AstraZeneca Revenue by Region; 2023 (Percentage, %)
Figure 94: Boehringer Ingelheim Pharmaceuticals, Inc. Net Sales by Business; 2023 (Percentage, %)
Figure 95: Amgen Inc. Revenues by Region; 2023 (Percentage, %)
Table 1: Global Range of Lung Cancer Treatment Cost
Table 2: New Product Development and Launches
Table 3: Global Lung Cancer Therapy Market Players by Product Pipeline
